FDA recall, , Moderate risk
Baxter Vancomycin, Insulin, Daptomycin and Other Injections
Vancomycin Injection, USP in 5% Dextrose has CGMP deviations.
Summary by Recall Canary from the FDA notice
What happened
Baxter Healthcare Corporation of Deerfield, Illinois, recalled several injectable products, including Vancomycin Injection, USP in 5% Dextrose, due to CGMP deviations. The recall began August 6, 2026, and was added to the FDA's Enforcement Report on August 28, 2026. Distribution included US Nationwide, Puerto Rico, and Chile.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is your container affected?
Match your product and all the details in one listed combination.
An NDC (National Drug Code) is usually printed on the drug's label.
Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA
- NDC
- 0338-0126-12
- Lot code
- NC188630
- NC188708
- NC188791
- NC188845
- NC188876
- NC188968
- NC193719
- NC193849
- NC194051
- NC194105
- NC195171
Pantoprazole Sodium in 0.9% Sodium Chloride Injection
- Strength
- 80 mg
- NDC
- 0338-9648-12
- Lot code
- NC194129
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA
- NDC
- 0338-9640-12
- Lot code
- NC193672
- NC193795
- NC194198
Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (
- Strength
- 5 mg/mL
- NDC
- 0338-3552-48
- Lot code
- NC188678
- NC188814
- NC188944
- NC193610
- NC193665
Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (
- Strength
- 5 mg/mL
- NDC
- 0338-3583-01
- Lot code
- NC193894
Daptomycin, in 0.9% Sodium Chloride Injection
- Strength
- 500 mg
- NDC
- 0338-0714-24
- Lot code
- NC188692
Clindamycin Injection USP in 5% Dextrose
- Strength
- 900 mg
- NDC
- 43066-995-24
- Lot code
- NC194068
- Strength
- 900 mg
- NDC
- 0338-3814-50
- Lot code
- NC185424
- NC185479
- NC193948
- Strength
- 600 mg
- NDC
- 0338-3612-50
- Lot code
- NC193764
- NC195232
- Strength
- 900 mg
- NDC
- 0338-4114-50
- Lot code
- NC194075
Famotidine Injection in Sodium Chloride Injection
- Strength
- 20 mg
- NDC
- 0338-5197-41
- Lot code
- NC188586
- NC188913
Daptomycin, in 0.9% Sodium Chloride Injection, 1
- Strength
- 000 mg
- NDC
- 0338-0718-12
- Lot code
- NC193856
Clindamycin Phosphate in 0.9% Sodium Chloride Injection
- Strength
- 600 mg
- NDC
- 0338-9549-50
- Lot code
- NC193689
Cardene IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection
- Strength
- 40 mg
- NDC
- 43066-016-10
- Lot code
- NC177818
- NC188869
Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA
- NDC
- 0338-9647-12
- Lot code
- NC185448
- NC192910
- NC195218
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
- Strength
- 400 mcg
- NDC
- 0338-9557-12
- Lot code
- NC188654
- NC188821
- NC193658
- NC193702
Nexterone (amiodarone HCI)
- Strength
- 360 mg
- NDC
- 43066-360-20
- Lot code
- NC177832
- NC185417
- NC185455
- NC188593
- NC188647
- NC188685
- NC188807
- NC188838
- NC188920
- NC193603
- NC193726
- NC193788
- NC193863
- NC193900
- NC194082
- NC194112
- NC194143
- NC195157
Recall details
- Company began the recall
- Sold in
US Nationwide; Puerto Rico; and Chile.
- Company
- Baxter Healthcare CorporationDeerfield, Illinois
- Hazard
- Manufacturing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99500
- Recall numbers
- D-0805-2026 to D-0821-2026
All recalls from Baxter Healthcare Corporation
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
